Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FAWFZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,436
Award facts
- Contract value 100% obligated
- $11,436.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $11,436.07 to DMS Pharmaceutical Group Inc. for RINVOQ ER 15 mg tablets (UU 30s) on September 4, 2025, with completion targeted for September 5, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, allowing the company to compete on a full and open basis leveraging its established market position within federal pharmaceutical procurement.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables firm fixed-price orders for comprehensive pharmaceutical products supporting Department of Defense medical supply requirements. DMS Pharmaceutical Group has consistently demonstrated its capability as a critical supplier in the federal pharmaceutical supply chain, delivering branded and generic prescription drugs, biologics, and medical consumables to military healthcare facilities nationwide. The RINVOQ ER medication supplied under this order supports the agency's ongoing pharmaceutical inventory needs for defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FAWFZ?
SPE2DB25FAWFZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FAWFZ worth?
The government has obligated $11,436 on SPE2DB25FAWFZ.
Is contract SPE2DB25FAWFZ an order under another contract?
Yes. SPE2DB25FAWFZ is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAWFZ competed?
The extent of competition for SPE2DB25FAWFZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award